Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China-Reference-Cited by-同舟云学术

Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China

Published:2022-04-29 Issue:1 Volume:39 Page:706-712
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Su Yan-Dong¹,Yang Zhi-Ran¹,Li Xin-Bao¹,Yu Yang²,Du Xue-Mei¹,Li Yan¹

Affiliation:

1. Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China

2. Beijing Shijitan Hospital, Beijing, China

Funder

National Natural Science Foundation of China

Beijing Municipal Administration of Hospitals’ Ascent Plan

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2022.2066728

Reference36 articles.

1. Peritoneal mesothelioma

2. Diffuse malignant peritoneal mesothelioma – An update on treatment

3. Peritoneal Metastases from Malignant Mesothelioma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma;Journal of Surgical Oncology;2024-09-10

2. Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma;Journal of Surgical Oncology;2024-08-25

3. Long-term survival in patients with PMP: a single-institutional retrospective study from China;World Journal of Surgical Oncology;2023-10-28

4. Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy;International Journal of Hyperthermia;2023-06-22

5. Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma;Cancer Control;2023-04